References

1 Huang, Q., Liu D, P. Majewski ,L. C. Schulte, J. M. Korn, R.A. Young, E. S. Lander, and N. Hacohen. 2001. The plasticity of dendritic cell responses to pathogens and their components.

ial pathogens. Proc. Natl. Acad. Sci. U.S.A. 99:1503-1508.

3 Boldrick, J. C. , A. A. Alizadeh, M. Diehn, S. Dudoit, C. L. Liu, C. E. Belcher, D. Botstein, L. M. Staudt, P. O. Brown, and D. A. Relman. 2002. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc. Natl. Acad.

Science 294:870-875.

2 Nau, G. J., J. F. Richmond, A. Schle singer, E. G. Jennings, E. S. Lander, and R. A. Young. 2002. Human macrophage activation programs induced by bacter

4 Chaussabel, D., R. T. Semnani, M. A. McDowell, D. Sacks, A. Sher, and T. B. Nutman. 2003. Unique gene expression profiles of human macrophages and dendritic cells to phylogenetically distinct parasites. Blood 102:672-681.

5 Prucha, M., A. Ruryk, H. Boriss, E. Moller, R. Zazula, I. Herold, R. A. Claus,

K. A. Reinhart, P. Deigner, and S. Russwurm. 2004. Expression profiling: toward an application in sepsis diagnostics. Shock 22:29-33.

6 O'Neil, D. A., E. M. Porter, D. Elewaut, G. M. Anderson, L. Eckmann, T. Ganz, and M. F. Kagnoff. 1999. Expression and regulation of the human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J. Immunol. 163:67186724.

7 Kagnoff,M. F., and L. Eckmann. 1997. Epithelial cells as sensors for microbial infection. J Clin. Invest. 100:6-10.

J. Fierer. 1995. Intestinal epithelial cells as watchdogs for the natural immune system. Trends Microbiol. 3:118-120.

9 Kagnoff,M. F., and L. Eckmann. 1997. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 100:6-10.

10 Sugiyama, T., and M. Asaka. Helicobac-ter pylori infection and gastric cancer. 2004. Med. Electron. Microsc. 2004 37:149-157.

11 Blanchard, T.G., M. L. Drakes, and S. J. Czinn. 2004. Helicobacter infection: pathogenesis. Curr. Opin. Gastroen-terol. 20:10-15.

12 Hatakeyama, M. 2004. Oncogenic mechanisms ofthe Helicobacter pylori CagA protein. Nat. Rev. Cancer 4:688694.

V. Brinkmann, W. Konig, T. F. Meyer, and S. Backert. 2004. Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect. Immun. 72:3646-3649.

D. M. Wallace, P. A. Robinson, and J. E. Crabtree. 2001. cDNA array analysis of cag pathogenicity island-associated Heli-cobacter pylori epithelial cell response genes. Infect. Immun. 69:6970-6980.

15 Keates, S., Y. S. Hitti, M. Upton, and C. P. Kelly. 1997. Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells. Gastroenterology. 113:1099-1109.

16 Peek, R. M. Jr., S. F. Moss, K. T. Tham, G. I. Perez-Perez, S. Wang, G. G. Miller, J. C. Atherton, and P. R. Holt, and M. J. Blaser. 1997. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apopto-sis. J. Natl. Cancer Inst. 89:863-868.

17 Schoenfeld, A. R., E. J. Davidowitz, and R. D. Burk. 2000. Elongin BC complex prevents degradation of von Hippel-Lin-dau tumor suppressor gene products. Proc. Natl. Acad. Sci. U. S. A. 97:85078512.

18 Wu, E., P. I. Croucher, and N. McKie. 1997. Expression ofmembers ofthe novel membrane linked metalloprotei-nase family ADAM in cells derived from a range of haematological malignancies. Biochem. Biophys. Res. Commun. 235:437-442.

19 Millichip, M.I., D. J. Dallas, E. Wu, S. Dale, and N. McKie. 1998. The metallo-disintegrin ADAM10 (MADM) from bovine kidney has type IV collagenase activity in vitro. Biochem. Biophys. Res. Commun. 245:594-598.

20 Lunn, C. A., X. Fan, B. Dalie, K. Miller, P. J. Zavodny, S. K. Narula, and D. Lun-dell. 1997. Purification of ADAM 10 from bovine spleen as a TNFalpha convertase. FEBS Lett. 400:333-335.

21 Guillemin, K., N. R. Salama, L. S. Tompkins, and S. Falkow. 2002. Cag pathogenicity island-specific responses of gastric epithelial cells to Helicobacter pylori infection. Proc. Natl. Acad. Sci. U.S.A. 99:15136-15141.

22 Crowe, S. E. 2005. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr. Opin. Gastroenterol. 21:32-38.

23 Boussioutas, A., H. Li, J. Liu, P. Waring, S. Lade, A. J. Holloway, D. Taupin,

K. Gorringe, I. Haviv, P. V. Desmond, and D. D. Bowtell. 2003. Distinctive patterns of gene expression in premalig-nant gastric mucosa and gastric cancer. Cancer Res. 63:2569-2577.

S. Cagnol, J. C. Chambard, S. Contamin S, V. de Thillot, I. Just, V. Ricci, E. Solcia, E. van Obberghen, and P. Boquet. 2000. The N-terminal 34 kDa fragment of Helicobacter pylori vacuolating cyto-toxin targets mitochondria and induces cytochrome c release. EMBO J. 19:63616370.

25 Yahiro, K., A. Wada, M. Nakayama, T. Kimura, K. Ogushi, T. Niidome, H. Aoyagi, K. Yoshino, K. Yonezawa, J. Moss, and T. Hirayama. 2003. Pro-tein-tyrosine phosphatase alpha, RPTP alpha, is a Helicobacter pylori VacA receptor. J. Biol. Chem. 278:19183-9.

26 Kimura, M., S. Goto, A. Wada, K. Yahiro, T. Niidome, T. Hatakeyama, H. Aoyagi, T. Hirayama, and T. Kondo. 1999. Vacuolating cytotoxin purified from Helicobacter pylori causes mitochon-drial damage in human gastric cells. Microb. Pathog. 26:45-52.

27 Norsett, K. G., A. Laegreid, H. Midel-fart, F. Yadetie, S. E. Erlandsen, S. Falk-mer, J. E. Gronbech, H. L. Waldum,

J. Komorowski, and A. K. Sandvik. 2004. Gene expression based classification of gastric carcinoma. Cancer Lett. 210:227-237.

28 Cornelis, G. R. 2002. The Yersinia Ysc-Yop 'type III' weaponry. Nat. Rev. Mol. Cell Biol. 3:742-752.

29 Sauvonnet, N., B. Pradet-Balade, J. A. Garcia-Sanz, and G. R. Cornelis. 2002. Regulation of mRNA expression in macrophages after Yersinia enterocoli-tica infection. Role of different Yop effectors. J. Biol. Chem. 277:2513325142.

30 Hoffmann, R., K. van Erp, K. Trulzsch, and J. Heesemann. 2004. Transcriptional responses of murine macrophages to infection with Yersinia entero-colitica. Cell. Microbiol. 6:377-390.

31 Bohn, E., S. Muller, J. Lauber, R. Gef-fers, N. Speer, C. Spieth, J. Krejci,

B. Manncke, J. Buer, A. Zell, and I.B. Autenrieth. 2004. Gene expression patterns of epithelial cells modulated by pathogenicity factors of Yersinia entero-colitica. Cell. Microbiol. 6:129-141.

32 Pepe, J. C., and V. L. Miller. 1993. Yersi-nia enterocolitica invasin: a primary role in the initiation of infection. Proc. Natl. Acad. Sci. U. S. A. 90:6473-6477.

33 Pepe, J. C., and V. L. Miller. 1993. The biological role of invasin during a Yersi-nia enterocolitica infection. Infect. Agents Dis. 2:236-241.

H. Bartels, S. Preger, J. P. Kraehenbuhl, E. Pringault, and I. B. Autenrieth. 2000. Translocation ofYersinia enterocolitica across reconstituted intestinal epithelial monolayers is triggered by Yersinia invasin binding to beta1 integrins apically expressed on M-like cells. Cell. Microbiol. 2:173-185.

35 Isberg, R. R., and J. M. Leong. 1990. Multiple beta 1 chain integrins are receptors for invasin, a protein that promotes bacterial penetration into mammalian cells. Immunity 60:861-71.

36 Kampik, D., R. Schulte, and I. B. Auten-rieth. 2000. Yersinia enterocolitica inva-sin protein triggers differential production of interleukin-1, interleukin-8, monocyte chemoattractant protein 1, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor alpha in epithelial cells: implications for understanding the early cytokine network in Yersinia infections. Infect. Immun. 68:2484-2492.

S. Fessele, C. A. Jacobi, M. Schaller, P. J. Nelson, and I. B. Autenrieth. 2000. Yer-sinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodi-mers. FASEB J. 14:1471-84.

38 Grassl, G. A., M. Kracht, A. Wiede-mann, E. Hoffmann, M. Aepfelbacher, C. von Eichel-Streiber, E. Bohn, and I.B. Autenrieth. 2003. Activation of NF-jB and IL-8 by Yersinia enterocolitica inva-sin protein is conferred by engagement of Rac1 and MAP kinase cascades. Cell. Microbiol. 5:957-971.

39 Orth, K. 2002. Function of the Yersinia effector YopJ. Curr. Opin. Microbiol. 5:38-43.

40 Ruckdeschel, K., O. Mannel, K. Richter, C. A. Jacobi, K. Trulzsch, B. Rouot, and J. Heesemann. 2001. Yersinia outer protein P ofYersinia enterocolitica simultaneously blocks the nuclear factor-kappa

B pathway and exploits lipopolysacchar-ide signaling to trigger apoptosis in macrophages. J. Immunol. 166:18231831.

41 Ayroldi, E., G. Migliorati, S. Bruscoli, C. Marchetti, O. Zollo, L. Cannarile, F. D'Adamio, and C. Riccardi. 2001. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB. Blood 98:743-753.

M. Watanabe, S. Gray, R. L. Haspel, D. J. Denkinger, R. Kawahara, H. Hauner, and M. K. Jain. 2003. The Kruppel-like factor KLF2 inhibits peroxisome prolif-erator-activated receptor-gamma expression and adipogenesis. J. Biol. Chem. 278:2581-2584.

43 Buckley, A. F., C. T. Kuo, and J. M. Leiden. 2001. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat. Immunol. 2:698-704.

44 Engel, M. E., P. K. Datta, and H. L. Moses. 1998. RhoB is stabilized by transforming growth factor beta and antagonizes transcriptional activation. J. Biol. Chem. 273:9921-9926.

45 Fritz, G., and B. Kaina. 2001. Ras-related GTPase Rhob represses NF-kappaB signaling. J. Biol. Chem. 276:3115-3122.

46 Mittelstadt, P. R., J. D. Ashwell. 2001. Inhibition ofAP-1 by the glucocorticoid-inducible protein GILZ. J. Biol. Chem. 276:29603-29610.

47 Juris, S. J., F. Shao, and J. E. Dixon. 2002. Yersinia effectors target mammalian signalling pathways. Cell. Microbiol. 4:201-211.

48 Chen, C. C., F. E. Mo, and L. F. Lau. 2001. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts.

J. Biol. Chem. 276:47329-47337.

49 Sadikot, R. T., T. S. Blackwell, J. W. Christman, and A. S. Prince. 2005. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia: the state ofthe art. Am. J. Respir. Crit. Care Med. 164:873-878.

50 Eberl, L., and B. Tummler. 2004. Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: genome evolution, interactions and adaptation. Int. J. Med. Microbiol. 294:123-131.

51 Ichikawa, J. K., A. Norris, M. G. Ban-gera, G. K. Geiss, A. B. 't Wout, R. E. Bumgarner, and S. Lory. 2000. Interaction ofPseudomonas aeruginosa with epithelial cells: identification of differentially regulated genes by expression microarray analysis of human cDNAs. Proc. Natl. Acad. Sci. U. S.A. 97:96599664.

52 Cobb, L. M., J. C. Mychaleckyj, D. J. Wozniak, and Y. S. Lopez-Boado. 2004. Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease. J. Immunol. 173:5659-5670.

53 Flo, T. H., L. Ryan, E. Latz, O. Takeuchi, B. G. Monks, E. Lien, O. Halaas,

S. Akira, G. Skjak-Braek, D. T. Golen-bock, and T. Espevik. 2002. Involvement of toll-like receptor (TLR) 2 and TLR4 in cell activation by mannuronic acid polymers. J. Biol. Chem. 277:35489-35495.

54 Muir, A., G. Soong, S. Sokol, B. Reddy, M. I. Gomez, A. van Heeckeren, and

A. Prince. 2004. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 30:777-783.

55 McMorran, B., L. Town, E. Costelloe, J. Palmer, J. Engel, D. Hume, and

B. Wainwright. 2003. Effector ExoU from the type III secretion system is an important modulator of gene expression in lung epithelial cells in response to Pseudomonas aeruginosa infection. Infect. Immun. 71:6035-6044.

56 Kelly-Wintenberg, K., andT. C. Montie. 1989. Cloning and expression of Pseudomonas aeruginosa flagellin in Escher-ichia coli. J. Bacteriol. 171:6357-6362.

57 Finck-Barbancon, V., and D. W. Frank. 2001. Multiple domains are required for the toxic activity ofPseudomonas aeru-ginosa ExoU. J. Bacteriol. 183:43304344.

58 Finck-Barbancon, V., J. Goranson,

L. Zhu, T. Sawa, J. P. Wiener-Kronish, S. M Fleiszig, C. Wu, L. Mende-Mueller L, and D. W. Frank. 1997. ExoU expression by Pseudomonas aeruginosa corre lates with acute cytotoxicity and epithelial injury. Mol. Microbiol. 25:547-57.

59 Hauser, A. R., P. J. Kang, and J. N. Engel. 1998. PepA, a secreted protein of Pseudomonas aeruginosa, is necessary for cytotoxicity and virulence. Mol. Microbiol. 27:807-818.

60 Garrity-Ryan, L., B. Kazmierczak,

R. Kowal, J. Comolli, A. Hauser, J. N. Engel. 2000. The arginine finger domain of ExoT contributes to actin cytoskeleton disruption and inhibition of internalization of Pseudomonas aeruginosa by epithelial cells and macrophages. Infect. Immun. 68:7100-7113.

61 Krall, R., G. Schmidt, K. Aktories, and J. T. Barbieri. 2000. Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein. Infect. Immun. 68:6066-6068.

62 Olenyuk, B. Z., G. J. Zhang , J. M. Klco, N. G. Nickols, W. G. Kaelin Jr., and P. B. Dervan. 2004. Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist. Proc. Natl. Acad. Sci. U.S.A. 101:16768-16773.

63 Bacon, A. L., and A. L. Harris. 2004. Hypoxia-inducible factors and hypoxic cell death in tumour physiology. Ann. Med. 36:530-539.

64 Leonard, M. O., D. C. Cottell, C. Godson, H. R. Brady, C. T. Taylor. 2003. The role of HIF-1 alpha in transcriptional regulation ofthe proximal tubular epithelial cell response to hypoxia.

J. Biol. Chem. 278:40296-40304.

65 Ang, S. O., H. Chen, K. Hirota, V. R. Gordeuk, J. Jelinek, Y. Guan, E. Liu, A. J. Sergueeva, G. Y. Miasnikova, D. Mole, P. H. Maxwell, D. W. Stockton, G. L. Semenza, and J. T. Prchal. 2002. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat. Genet. 32:614-621.

66 Lai, W. S., E. Carballo, J. R. Strum, E. A. Kennington, R. S. Phillips, P. J. Black-shear. 1999. Evidence that tristetraprolin binds to AU-rich elements and promotes the deadenylation and destabili-zation oftumor necrosis factor alpha mRNA. Mol. Cell Biol. 19:4311-4323.

67 Keyse, S. M. 1995. An emerging family of dual specificity MAP kinase phospha tases. Biochim. Biophys. Acta. 1265:152-160.

68 Williams, T. M., D. Moolten, J. Burlein, J. Romano, R. Bhaerman, A. Godillot, M. Mellon, F. J. Rauscher III, and J. A. Kant. 1991. Identification of a zinc finger protein that inhibits IL-2 gene expression. Science 254:1791-1794.

69 Yasui, D. H., T. Genetta, T. Kadesch, T. M Williams, S. L. Swain, L. V. Tsui, and B. T. Huber. 1998. Transcriptional repression of the IL-2 gene in Th cells by ZEB. J. Immunol. 160:4433-4440.

70 DiMango, E., A. J. Ratner, R. Bryan, S. Tabibi, and A. Prince. 1998. Activation ofNF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells.

J. Clin. Invest 101:2598-2605.

71 Virella-Lowell, I., J. D. Herlihy, B. Liu, C. Lopez, P. Cruz, C. Muller, H. V. Baker, and T. R. Flotte. 2004. Effects of CFTR, interleukin-10, and Pseudomonas aeruginosa on gene expression profiles in a CF bronchial epithelial cell Line. Mol. Ther. 10:562-573.

72 Chomel, B. B., R. W. Kasten, J. E. Sykes, H. J. Boulouis, and E. B. Breitschwerdt.

2003. Clinical impact ofpersistent Bartonella bacteremia in humans and animals. Ann. N. Y. Acad. Sci. 990:267278.

2004. Host cell modulation by human, animal and plant pathogens. Int. J. Med. Microbiol. 293:463-470.

74 Kempf, V. A. , M. Lebiedziejewski, K. Alitalo, J. H. Wälzlein, U. Ehehalt,

J. Fiebig, B. Schütt, C. Sander, S. Müller, G. Grassl, B. Brem, and I. B. Auten-rieth. 2005. Activation of hypoxia-indu-cible factor-1 in bacillary angiomatosis: evidence for a role ofHIF-1 in bacterial infections. Circulation. 111:1054-1062.

75 Semenza, G. L. 2001. HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Immunity 107:1-3.

76 Pugh, C. W., and P. J. Ratcliffe. 2003. Regulation ofangiogenesis by hypoxia: role of the HIF system. Nat. Med. 9:677-684.

77 Kempf,V. A., M. Schaller, S. Behrendt, B. Volkmann, M. Aepfelbacher, I. Cak-

man, and I. B. Autenrieth. 2000. Interaction of Bartonella henselae with endothelial cells results in rapid bacterial rRNA synthesis and replication. Cell. Microbiol. 2:431-441.

78 Kempf,V. A., N. Hitziger, T. Riess, and I.B. Autenrieth. 2002. A two-step pathogenicity strategy of bacteria promotes tumour formation: a common strategy shared by plant and human pathogens? Trends Microbiol. 10:269-275.

79 Moreilhon, C., D. Gras, C. Hologne, O. Bajolet, F. Cottrez, V. Magnone,

M. Merten, H. Groux, E. Puchelle, and P. Barbry. 2005. Live Staphylococcus aureus and bacterial soluble factors induce different transcriptional responses in human airway cells. Phy-siol. Genomics 20:244-255.

80 Pahl, H. L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853-6866.

81 Hayden, M. S., and S. Ghosh. 2004. Signaling to NF-kappaB. Genes Dev. 18:2195-2224.

82 Takeda, K., and S. Akira. 2005. Toll-like receptors in innate immunity. Int. Immunol. 17:1-14.

83 Schmid, Y., G. A. Grassl, O. T. Buhler, M. Skurnik, and I. B. Autenrieth, and E. Bohn. 2004. Yersinia enterocolitica adhesin A induces production of inter-leukin-8 in epithelial cells. Infect. Immun. 72:6780-6789.

84 Murillo, L. S., S. A. Morre, and A. S. Pena. 2003. Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response. Drugs Today (Barc. ) 39:415-438.

85 Lawrence, T., A Puel, J. Reichenbach, C. L. Ku, A. Chapgier, E. Renner,

V. Minard-Colin, M. Ouachee, and J. L. Casanova. 2005. Autosomal-dominant primary immunodeficiencies. Curr. Opin. Hematol. 12:22-30.

A. Puel, H. von Bernuth, O. F. Santos, T. Lawrence, H. H. Chang, H. Al Mousa, C. Picard, and J. L. Casanova. 2005. Inherited disorders of human Toll-like receptor signaling: immunolo-gical implications. Immunol. Rev. 203:10-20.

87 Niehues, T., J. Reichenbach, J. Neubert, S. Gudowius, A. Puel, G. Horneff,

E. Lainka, U. Dirksen, H. Schroten, R. Doffinger, and J. L. Casanova, and V. Wahn. 2004. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidro-tic ectodermal dysplasia. J. Allergy Clin. Immunol. 114:1456-62.

F. Geissmann, J. Feinberg, A. Durandy,

C. Bodemer, S. Kenwrick, S. Dupuis-Girod, S. Blanche, P. Wood, S. H. Rabia,

F. Le Deist, S. M. Holland, K. Belani, D. S. Kumararatne, A. Fischer, R. Shapiro, M. E. Conley, E. Reimund, H. Kalhoff, M. Abinun, A. Munnich, A. Israel, G. Courtois, and J. L. Casanova. 2001. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat. Genet. 27:277-285.

89 Zonana, J., M. E. Elder, L. C. Schneider, S. J. Orlow, C. Moss, M. Golabi, S. K. Shapira, P. A. Farndon, D. W. Wara,

S. A. Emmal, and B. M. Ferguson. 2000. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pig-menti and due to mutations in IKK-gamma (NEMO). Am. J. Hum. Genet. 67:1555-1562.

90 Orange, J. S, A. Jain, Z. K. Ballas, L. C. Schneider, R. S. Geha, and F. A. Bonilla. 2004. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J. Allergy Clin. Immunol. 113:725-33.

91 Orange, J. S., S. R. Brodeur, A. Jain, F. A. Bonilla, L. C. Schneider,

R. Kretschmer, S. Nurko, W. L. Rasmus-sen, J. R. Kohler, S. E. Gellis, B. M. Ferguson, J. L. Strominger, J. Zonana, N. Ramesh, Z. K. Ballas, and G. S. Geha. 2002. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J. Clin. Invest. 109:1501-1509.

92 Courtois, G., A. Smahi, J. Reichenbach, R. Doffinger, C. Cancrini, M. Bonnet, A. Puel, C. Chable-Bessia, S. Yamaoka, J. Feinberg, S. Dupuis-Girod, C. Bode-

mer, S. Livadiotti, F. Novelli, P. Rossi, A. Fischer, A. Israel, A. Munnich, F. Le Deist, and J. L. Casanova. 2003. A hyper-morphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and Tcell immunodeficiency. J. Clin. Invest 112:1108-1115.

93 MacLennan, C., C. Fieschi, D. A. Lammas, C. Picard, S. E. Dorman, O. Sanal, J. M. MacLennan, S. M. Holland,

T. H. Ottenhoff,J. L. Casanova, and D. S. Kumararatne. 2004. Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J. Infect. Dis. 190:1755-1777.

94 Emonts, M., J. A. Hazelzet, R. de Groot, and P. W. Hermans. 2003. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect. Dis. 3:565577.

J. Loggins, T. E. Kruger, and R. J. Baier. 2004. Tumor necrosis factor alpha - 308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr. Infect. Dis. J. 23:424-428.

96 Jiao, J., and J. B. Wang. 2005. Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C. Hepatobiliary Pancreat. Dis. Int. 4:80-83.

97 Vidigal, P. G., J. J. Germer, and N. N. Zein. 2002. Polymorphisms in the inter-leukin-10, tumor necrosis factor-alpha, and transforming growth factor-betal genes in chronic hepatitis C patients treated with interferon and ribavirin.

How To Win Your War Against Allergies

How To Win Your War Against Allergies

Not Able To Lead A Happy Life Because Of Excessive Allergies? Want To Badly Get Rid Of Your Allergy Problems, But Are Super Confused And Not Sure Where To Even Start? Don't Worry, Help Is Just Around The Corner Revealed The All-In-One Power Packed Manual Containing Ample Strategies And Little-Known Tips To Get Rid Of Any Allergy Problems That Are Ruining Your Life Learn How You Can Eliminate Allergies Completely Reclaim Your Life Once Again

Get My Free Ebook


Post a comment